Skip to main content

View full-text article in PMC

. 2001 Dec 28;1:7. doi: 10.1186/1471-244X-1-7

Table 1.

Baseline characteristics of the three treatment groups.

	Olanzapine	Risperidone	Haloperidol
	N = 2128	N = 417	N = 112	p-value
Age (years)	35.6 ± 11.7	34.4 ± 11.2	34.3 ± 10.4	NS
Sex (% females)	36.3	34.1	39.3	NS
Disease Duration (years)	11.1 ± 9.6	10.3 ± 9.0	9.5 ± 9.5	NS

Schizophrenia subtype
(%)
• Paranoid	64.7	65.1	72.3
• Undifferentiated	13.6	13.7	11.6
• Residual	12.8	11.8	5.4	NS
• Disorganized	8.4	8.4	10.7
• Catatonic	0.5	1.0	0.0
Baseline CGI-S	4.66 ± 0.9^1,2	4.53 ± 0.9	4.9 ± 0.91	¹ p < 0.005 (RIS)
				² p < 0.050 (HAL)
Baseline GAF	44.9 ± 14.8^3,4	46.7 ± 14.6	40.7 ± 16.2	³ p < 0.050 (RIS)
				⁴ p <0.005 (HAL)